Literature DB >> 18753303

Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells.

John Holian1, Weier Qi, Darren J Kelly, Yuan Zhang, Ellein Mreich, Carol A Pollock, Xin-Ming Chen.   

Abstract

Krüppel-like factor 6 (KLF6) is a DNA-binding protein containing a triple zinc-fingered motif and plays a key role in the regulation of cell proliferation, differentiation, and development. More recently it has been implicated in hepatic fibrosis via its binding to the transforming growth factor (TGF)-beta control element. In the kidney, epithelial-mesenchymal transition (EMT) is a major contributor to the pathogenesis of renal fibrosis, with TGF-beta1 being a key mediator of EMT. The present study aimed to determine the role of KLF6 and TGF-beta1 in EMT in proximal tubule cells. To determine the relevance in clinical disease, KLF6 was measured in kidneys of streptozotocin-induced diabetic Ren-2 rats and in cells exposed to high (30 mM) glucose. TGF-beta1 was confirmed to induce EMT by morphological change, loss of E-cadherin, and gain in vimentin expression. KLF6 mRNA expression was concomitantly measured. To determine the role of KLF6 in EMT, the above markers of EMT were determined in KLF6-silenced (small interfering RNA) and KLF6-overexpressing proximal tubule cells. KLF6 overexpression significantly promoted a phenotype consistent with EMT. High glucose induced KLF6 in proximal tubule cells (P < 0.05). This increase in KLF6 in response to high glucose was TGF-beta1 mediated. In an in vivo model of diabetic nephropathy KLF6 increased at week 8 (P < 0.05). KLF6 plays a permissive role in TGF-beta1-induced EMT in proximal tubule cells. Its upregulation in in vivo models of diabetic nephropathy suggests it as a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753303      PMCID: PMC2584898          DOI: 10.1152/ajprenal.00055.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  36 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

3.  KLF6, a candidate tumor suppressor gene mutated in prostate cancer.

Authors:  G Narla; K E Heath; H L Reeves; D Li; L E Giono; A C Kimmelman; M J Glucksman; J Narla; F J Eng; A M Chan; A C Ferrari; J A Martignetti; S L Friedman
Journal:  Science       Date:  2001-12-21       Impact factor: 47.728

4.  Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

Authors:  M D Oldfield; L A Bach; J M Forbes; D Nikolic-Paterson; A McRobert; V Thallas; R C Atkins; T Osicka; G Jerums; M E Cooper
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta.

Authors:  J Zavadil; M Bitzer; D Liang; Y C Yang; A Massimi; S Kneitz; E Piek; E P Bottinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

7.  Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells.

Authors:  S Kojima; S Hayashi; K Shimokado; Y Suzuki; J Shimada; M P Crippa; S L Friedman
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.

Authors:  Yung-Ming Jeng; Hey-Chi Hsu
Journal:  Int J Cancer       Date:  2003-07-10       Impact factor: 7.396

10.  Differential regulation of Krüppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines.

Authors:  Timothy E Cullingford; Matthew J Butler; Andrew K Marshall; El Li Tham; Peter H Sugden; Angela Clerk
Journal:  Biochim Biophys Acta       Date:  2008-03-25
View more
  35 in total

1.  In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line.

Authors:  Romina Bertinat; Pamela Silva; Elizabeth Mann; Xuhang Li; Francisco Nualart; Alejandro J Yáñez
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

Review 2.  TGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis.

Authors:  Kaoru Kahata; Varun Maturi; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

3.  Loss of Krüppel-like factor 6 cripples podocyte mitochondrial function.

Authors:  Jeffrey B Kopp
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808

Review 4.  The critical role of Krüppel-like factors in kidney disease.

Authors:  Sandeep K Mallipattu; Chelsea C Estrada; John C He
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-16

5.  ETS2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting JUNB transcription.

Authors:  Fang Yao; Xiaojing Wang; Zhong-Kai Cui; Haibing Lan; Xiaolan Ai; Qiancheng Song; Zhenguo Chen; Jun Yang; Bingyi Wu; Xiaochun Bai
Journal:  Lab Invest       Date:  2019-10-22       Impact factor: 5.662

6.  Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.

Authors:  Sylvia J Horne; Jessica M Vasquez; Yiqing Guo; Victoria Ly; Sian E Piret; Alexandra R Leonardo; Jason Ling; Monica P Revelo; Daniel Bogenhagen; Vincent W Yang; John C He; Sandeep K Mallipattu
Journal:  Diabetes       Date:  2018-08-16       Impact factor: 9.461

Review 7.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

8.  KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.

Authors:  Raheleh Hatami; Anieta M Sieuwerts; Sudeh Izadmehr; Zhong Yao; Rui Fang Qiao; Luena Papa; Maxime P Look; Marcel Smid; Jessica Ohlssen; Alice C Levine; Doris Germain; David Burstein; Alexander Kirschenbaum; Analisa DiFeo; John A Foekens; Goutham Narla
Journal:  Sci Transl Med       Date:  2013-01-23       Impact factor: 17.956

9.  KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells.

Authors:  Hui Zhang; Lili Liu; Yafang Wang; Guohong Zhao; Rougang Xie; Changhao Liu; Xiao Xiao; Kaichun Wu; Yongzhan Nie; Hongbo Zhang; Daiming Fan
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-16       Impact factor: 4.553

Review 10.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.